CRVO Common Stock · Transaction May 23, 2014 · Filed Jun 10, 2014 · Amount pending receipt enrichment
NASDAQ NMS - GLOBAL MARKET · CRVO
+0.76% · +$0.0200 · Vol Not reported
Pre-market · updated 04:21:39 ET
CervoMed Inc
Biotechnology
$2.64
Veridion Score
BETALOW CONF · 5/6 factorsFri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET · CRVO
MethodologySentiment absence reason unknown
CRVO
CervoMed Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
SELL BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
43/ 100
Veridion Score
SELL BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is CRVO moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About CervoMed Inc
PHARMACEUTICAL PREPARATIONSListed since
1996
Employees
15
Country
US
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$2.62
Last session
Day high
$2.62
Last session
Day low
$2.62
Last session
Previous close
$2.62
52W high
$10.69
-75.30% from high
52W low
$2.25
5% of range
Market cap
$39.6M
EPS
$-0.6400
Beta
2.72
Shares out
15.1M
Avg volume
479.2K
VWAP
$2.62
Last session
Price history computed in-house
1W
+1.15%
1M
-0.75%
3M
-13.44%
1Y
-71.08%
YTD
-66.58%
SMA 50 $3.06 · below
SMA 200 $4.88 · below
52W position 5%
CRVO overview
Related filings and maps
Public disclosures
Congress activity in CRVO
Official filing ↗
Federal contracts
CRVO contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CRVO in this window.
Lobbying spend
CRVO lobbying filings, year to date.
Registered lobbying filings matched to CervoMed Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CRVO in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for CRVO.
Options
Sovereign unlock shows live options positioning for CRVO.